M.D. Sass LLC’s Meta Platforms (Facebook) META Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,365
Closed -$2.31M 32
2022
Q1
$2.31M Buy
10,365
+890
+9% +$222K 0.39% 25
2021
Q4
$3.19M Buy
9,475
+3,234
+52% +$1.07M 0.5% 26
2021
Q3
$2.12M Sell
6,241
-2,894
-32% -$1.04M 0.36% 30
2021
Q2
$3.18M Sell
9,135
-47,224
-84% -$15.1M 0.53% 26
2021
Q1
$16.6M Buy
56,359
+46,034
+446% +$12.4M 2.92% 19
2020
Q4
$2.82M Sell
10,325
-47,655
-82% -$13.1M 0.6% 26
2020
Q3
$15.2M Sell
57,980
-13,869
-19% -$3.58M 3.77% 13
2020
Q2
$16.3M Buy
71,849
+28,709
+67% +$5.99M 4.33% 7
2020
Q1
$7.2M Buy
+43,140
New +$8.45M 2.61% 24

Other funds holding META

M.D. Sass LLC's META Position: Q2 2022 in Review

M.D. Sass LLC sold out of Meta Platforms (Facebook) (META) in Q2 2022, closing a stake of 10,365 shares — an estimated $2.31M sold.

M.D. Sass LLC first reported a position in META in Q1 2020 and held it in 9 quarters. The position peaked at $16.6M in Q1 2021. 3,074 funds tracked by Wall St. Rank hold META as of Q2 2022.

  • M.D. Sass LLC reported no remaining Meta Platforms (Facebook) position as of Q2 2022 after selling out during the quarter.
  • M.D. Sass LLC sold 10,365 Meta Platforms (Facebook) shares in Q2 2022, an estimated $2.31M.
  • M.D. Sass LLC first reported a position in Meta Platforms (Facebook) in Q1 2020 and held it in 9 quarters.
  • M.D. Sass LLC's Meta Platforms (Facebook) position peaked at $16.6M in Q1 2021.
  • 3,074 funds tracked by Wall St. Rank held Meta Platforms (Facebook) as of Q2 2022.

Based on M.D. Sass LLC's 13F filing for Q2 2022, filed 15 Aug 2022.